- Home
- PRVA
as 11-04-2025 3:58pm EST
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Upcoming Earnings Alert:
Get ready for potential market movements as Privia Health Group Inc. PRVA prepares to release earnings report on 06 Nov 2025.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | ARLINGTON |
| Market Cap: | 3.1B | IPO Year: | 2021 |
| Target Price: | $29.08 | AVG Volume (30 days): | 722.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.11 | EPS Growth: | -8.47 |
| 52 Week Low/High: | $18.50 - $26.49 | Next Earning Date: | 11-06-2025 |
| Revenue: | $1,900,071,000 | Revenue Growth: | 12.05% |
| Revenue Growth (this year): | 96.9% | Revenue Growth (next year): | 1.02% |
Latest Privia Health Group Inc. News
PRVA Breaking Stock News: Dive into PRVA Ticker-Specific Updates for Smart Investing
StockStory
15 days ago
Q2 Rundown: Privia Health (NASDAQ:PRVA) Vs Other Healthcare Technology for Providers Stocks
StockStory
16 days ago
3 Overrated Stocks That Fall Short
StockStory
a month ago
3 Cash-Heavy Stocks We Keep Off Our Radar
Simply Wall St.
2 months ago
Privia Health Group (NASDAQ:PRVA) May Have Issues Allocating Its Capital
StockStory
2 months ago
3 Reasons to Sell PRVA and 1 Stock to Buy Instead
StockStory
4 months ago
The Top 5 Analyst Questions From Privia Health’s Q1 Earnings Call
Argus Research
4 months ago
PRVA: Lowering target price to $24.00
StockStory
5 months ago
3 Small-Cap Stocks in Hot Water
Compare PRVA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRVA Privia Health Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.